Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




PCR-Based POC Molecular Diagnostic System to Combat Infectious Diseases

By LabMedica International staff writers
Posted on 28 Jan 2025

Chlamydia, Gonorrhea, and Trichomoniasis are among the most common sexually transmitted infections (STIs) worldwide, with an estimated 129 million, 82 million, and 151 million cases respectively reported in 2020. More...

Detecting these infections accurately typically relies on PCR-based molecular diagnostics, which have traditionally been carried out in centralized laboratories that require significant infrastructure. This setup limits accessibility in low- and middle-income countries where medical resources are often scarce. Now, a point-of-care (POC) molecular diagnostic device integrates all processes into a single, compact instrument to provide a rapid, reliable solution for detecting STIs, enabling timely interventions in resource-constrained settings.

Kryptos Biotechnologies (Hayward, CA, USA) is advancing its proprietary PCR-based POC molecular diagnostic system, the KUICK System, designed to combat infectious diseases and enhance healthcare outcomes globally. Kryptos is collaborating with Osang Healthcare (Gyeonggi-do, Republic of Korea) for a research project that will focus on developing molecular diagnostic reagents for STIs. The aim of this collaboration is to create a multiplex STI diagnostic test capable of detecting Chlamydia, Gonorrhea, and Trichomoniasis in under 30 minutes from a single patient sample.

As part of this collaboration, Osang will develop real-time PCR reagents, while Kryptos will focus on optimizing the KUICK System, particularly its innovative cartridge with integrated sample preparation chemistries. The system’s performance is also being improved to ensure reliability in diverse healthcare settings. In developed countries, the device will allow smaller clinics to offer accurate, same-day results, thereby significantly improving patient care.

“Our proprietary photothermal heating technology enables the KUICK System to meet diverse market demands for speed, accuracy, cost-efficiency, and portability,” said Dr. Jun Ho Son, CTO of Kryptos Biotechnologies and principal investigator of the project. “We are committed to ensuring this product makes a meaningful impact on healthcare environments, particularly in low- and middle-income countries.”

Related Links:
Kryptos Biotechnologies 
Osang Healthcare


New
Gold Member
Hematology Analyzer
Medonic M32B
Serological Pipet Controller
PIPETBOY GENIUS
New
Automated Chemiluminescence Immunoassay Analyzer
MS-i3080
New
6 Part Hematology Analyzer with RET + IPF
Mispa HX 88
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Hematology

view channel
Image: The microfluidic device for passive separation of platelet-rich plasma from whole blood (Photo courtesy of University of the Basque Country)

Portable and Disposable Device Obtains Platelet-Rich Plasma Without Complex Equipment

Platelet-rich plasma (PRP) plays a crucial role in regenerative medicine due to its ability to accelerate healing and repair tissue. However, obtaining PRP traditionally requires expensive centrifugation... Read more

Immunology

view channel
Image: PD-1 protein blockade is the standard treatment for advanced melanoma among the different types of immunotherapy (Photo courtesy of 123RF)

Precision Tool Predicts Immunotherapy Treatment Failure in Melanoma Patients

Melanoma, though accounting for only about 4% of skin tumors, is the deadliest form of skin cancer due to its high potential to metastasize. While immunotherapy, especially PD-1 protein blockade, has revolutionized... Read more

Pathology

view channel
Image: Researchers have developed a novel method to analyze tumor growth rates (Photo courtesy of Adobe Stock)

Novel Method To Analyze Tumor Growth Rates Helps Tracks Progression Between Diagnosis and Surgery

Patients diagnosed with breast cancer often worry about how quickly their tumors grow while they wait for surgery, and whether delays in treatment might allow the disease to spread beyond the point of cure.... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.